Ackman Calls PSUS Trading Discount "Absurd" — Here's What's Going On

Bill Ackman told analysts on Pershing Square's Q2 2026 earnings call that "the trading of PSUS is frankly absurd" and said the firm intends to address the discount at which the closed-end fund's shares trade relative to net asset value. The comments, made August 13, 2026, come one day after Pershing Square Holdings published its own semiannual financial statements including the Investment Manager's Report, and two days after Pershing Square USA released its 2026 Semi-Annual Report (Investing.com).

A closed-end fund, for those unfamiliar, raises a fixed pool of capital through an IPO and then lists its shares on an exchange. Those shares then trade freely at whatever price the market sets — which can be above or below the value of the fund's underlying holdings, known as net asset value, or NAV. When the share price is below NAV, the fund is said to trade at a discount. When it's above, it trades at a premium.

Pershing Square USA, Ltd. — listed on the New York Stock Exchange under the ticker PSUS with Ackman as CEO and Ryan Israel as CIO — reported NAV of $50.32 per share in its semi-annual filing dated August 11, 2026. The fund's NAV has gained approximately 2% since its IPO. IPO investors, however, are down 5.9% on their initial allocation (PSUS Semi-Annual Report).

The divergence between a rising NAV and a declining share price for IPO buyers is the mechanical signature of a widening discount. Think of it this way: if you bought a house for $100,000 and the property's appraised value rose to $102,000, but the market would only pay you $94,100 for it, you'd be down 5.9% even though the underlying asset went up 2%. The difference between those two numbers — roughly 7.9 percentage points — is the discount that has opened up since PSUS listed.

Ackman's frustration is not subtle. Calling the trading level "absurd" on a recorded earnings call signals that management views the discount as a mispricing rather than a reflection of portfolio quality. The stated intent to "address" the discount leaves the mechanism unspecified. Closed-end fund sponsors have a familiar toolkit for narrowing persistent discounts: share repurchases (buying back their own shares), tender offers (inviting shareholders to sell back at or near NAV), NAV-based distribution policies, or in extreme cases, conversion to an open-end structure where shares redeem directly at NAV. Which lever Pershing Square USA might pull remains undisclosed.

The parallel Pershing Square Holdings vehicle offers a useful reference point. PSH's 2026 Annual Investor Presentation, uploaded February 2026, reported NAV growth of 20.9% alongside total shareholder return figures (PSH Annual Investor Presentation). PSH, which trades on Euronext Amsterdam, has navigated its own discount dynamics over the years. The UK-listed closed-end fund sector has long grappled with discounts as a structural feature, not an anomaly, and the mechanisms for addressing them are well established in that market.

The broader context here is the IPO mechanics that PSUS's numbers lay bare. Closed-end fund IPOs typically price at a premium to NAV because underwriting fees and issuing costs are deducted from the gross proceeds. An investor who buys at the IPO effectively pays NAV plus those costs, meaning the fund must generate immediate positive returns simply for the share price to break even before any discount opens. For PSUS, the combination of IPO-cost drag and subsequent market discount has produced a 5.9% loss for day-one investors even as the underlying portfolio has appreciated.

The earnings call transcript also covers Pershing Square Holdings' Q2 2026 results, which Ackman characterized as a strong start to the period (Yahoo Finance). PSH's semiannual financial statements and the Investment Manager's Report were published August 12, 2026, with the Materials page also listing July 2026 materials and prior annual reports (PSH Materials).

For portfolio managers and analysts tracking the Pershing Square complex, the PSUS discount situation warrants attention on several fronts. First, any buyback or tender offer would require capital deployment that affects the fund's investment capacity. Second, the optics of a discount on a fund managed by one of the most prominent activist investors in the market carry reputational weight that extends beyond PSUS's own NAV. Third, the gap between PSH's reported 20.9% NAV growth and PSUS's 2% gain since IPO raises questions about portfolio overlap, timing, and whether the two vehicles offer materially different exposure to the same underlying strategy.

None of these questions has a public answer yet. Ackman has signaled intent, not a specific plan. The discount could narrow on its own if market sentiment shifts, or it could persist and force management's hand into a more structural remedy. For now, the number that matters is the gap: NAV up 2%, IPO investors down 5.9%, and a manager who calls the spread "absurd."